Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.2%

15 terminated/withdrawn out of 1239 trials

Success Rate

93.0%

+6.5% vs industry average

Late-Stage Pipeline

11%

135 trials in Phase 3/4

Results Transparency

5%

9 of 200 completed trials have results

Key Signals

327 recruiting9 with results7 terminated8 withdrawn

Enrollment Performance

Analytics

N/A
445(54.2%)
Phase 2
146(17.8%)
Phase 4
79(9.6%)
Phase 1
72(8.8%)
Phase 3
56(6.8%)
Early Phase 1
23(2.8%)
821Total
N/A(445)
Phase 2(146)
Phase 4(79)
Phase 1(72)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1239)

Showing 20 of 1239 trials
NCT07643922Not ApplicableNot Yet Recruiting

Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage

Role: collaborator

NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07641647Phase 4Not Yet Recruiting

The Effect of Bupivacaine Liposomes on Postoperative Pain in Lung Transplant Patients After Intercostal Nerve Block: a Randomized Controlled Study

Role: lead

NCT07642934Not ApplicableNot Yet Recruiting

A Comparative Study of the Efficacy of Myopia Control Lenses With Different Mechanisms on Controlling Myopia Progression in Patients With Intermittent Exotropia

Role: lead

NCT07417800Recruiting

Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning

Role: lead

NCT06711016Not ApplicableRecruiting

Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR

Role: collaborator

NCT07154433Not ApplicableCompleted

A Study on Reducing Opioid Use After Ankle Arthroscopy

Role: lead

NCT06882915Phase 1Not Yet Recruiting

Efficacy and Safety of Trifluridine/Tipiracil (TAS-102) Combined With Bevacizumab and Serplulimab in Patients With Metastatic Colorectal Cancer Undergoing Cytoreductive Surgery: A Single-Arm, Single-Center Clinical Study

Role: lead

NCT05921695Not ApplicableTerminated

The Relationship Between Normal Saline Infusion and Acute Kidney Injury in Heat Stroke

Role: lead

NCT07625514Not ApplicableNot Yet Recruiting

24-Week Recurrence Rate of Gout Following Firsekibart Treatment

Role: lead

NCT07627516Not ApplicableRecruiting

Clinical Study of the Efficacy and Safety of Spinal Cord Stimulation in Patients With Limb Motor Dysfunction Following Stroke

Role: lead

NCT07616440Not ApplicableRecruiting

Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer

Role: lead

NCT07316049Not ApplicableNot Yet Recruiting

Construction and Evaluation of an Intelligent Decision System for Reperfusion Therapy in Acute Ischemic Stroke

Role: lead

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT07314996Not ApplicableRecruiting

Laparoscopic Versus Open Surgery for Colon Cancer With Visceral Obesity

Role: lead

NCT07622576Not ApplicableNot Yet Recruiting

A Comparative Study of the Efficacy of AR Based Amblyopia Training Therapy and Occlusion Therapy in Older Children and Adults With Amblyopia

Role: lead

NCT07623213Not ApplicableNot Yet Recruiting

AI-Guided Intensified Follow-up After Surgery for Acute Type A Aortic Dissection

Role: lead

NCT06012760Not ApplicableRecruiting

The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion

Role: lead

NCT07616531Not ApplicableNot Yet Recruiting

Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled Trial

Role: lead

NCT07616453Phase 2Recruiting

Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer

Role: lead